FGF23 and left ventricular hypertrophy: To this end, we have investigated whether circulating levels of FGF23 and α-Klotho were associated with the left ventricular ejection fraction (LVEF) and left ventricular hypertrophy independent of these other calcium-phosphorus metabolism-related factors in cardiovascular inpatients, a population at high risk for cardiac abnormalities.